Advertisement
According to the study, STEMI patients undergoing multi-vessel PCI were more likely to be male, experience cardiogenic shock and have a drug-eluting stent. They also experience increased unadjusted in-hospital mortality, are more likely to experience Acute Renal Failure, and have a lower incidence of CABG than those undergoing single vessel PCI.
Advertisement
The research, funded and conducted by Cardiac Data Solutions, studied data on Medicare beneficiaries (MB) with a primary diagnosis of STEMI (first diagnosis code) that underwent a PCI during hospitalization between October 1, 2006 and September 30, 2007 and included 24,189 MB.
The study compared the following clinical outcomes between the MB undergoing single-vessel versus multi-vessel PCI:
"The study supports the current recommendations that STEMI patients undergo culprit vessel PCI only, however, prospective assessment of this question is needed to identify the best treatment strategy for patients with STEMI and multi-vessel CAD," said April Simon, RN, MSN, president of Cardiac Data Solutions and one of the researchers.
Other researchers included: Phillip P. Brown, cardiovascular surgeon (retired) and past chairman, Department of Surgery, Centennial Medical Center; David J. Cohen, MD, interventional cardiologist and director, Cardiovascular Research, Mid America Heart Institute, St. Luke's Hospital; Matthew R. Reynolds, MD, electrophysiologist and director, Economics and Quality of Life Assessment Group, Harvard Clinical Research Institute; and Steven D. Culler, PhD, associate professor, Rollins School of Public Health, Emory University.
About Cardiac Data Solutions, Inc. (CDS)
Founded in 1999, Cardiac Data Solutions, Inc. (CDS) provides consultation services, data analysis, clinical benchmarks, management tools, research support services and leadership training to hospitals, physicians, payors, manufacturers and the financial community. CDS is focused solely on the cardiovascular market with the primary mission of supporting and improving clinical and business decisions to improve the quality of patient care. Using proprietary data analysis tools with comprehensive and current data on clinical outcomes, CDS helps identify opportunities for improvement and develops evidence-based strategies to achieve them. For more information, visit http://www.cardiacdatasolutions.com.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
-- Acute renal failure -- New-onset hemodialysis -- Any vascular complication -- Observed mortality -- Expected mortality -- Stent type and usage
SOURCE Cardiac Data Solutions, Inc.
